feed,title,long_url,short_url
Benzinga,Entasis Therapeutics to Present at the H.C. Wainwright BioConnect 2021 Conference,https://www.benzinga.com/pressreleases/21/01/g19056315/entasis-therapeutics-to-present-at-the-h-c-wainwright-bioconnect-2021-conference,https://j.mp/3niNgDb
Benzinga,Cabaletta Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19056304/cabaletta-bio-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference,https://j.mp/3oivfq1
Benzinga,eFFECTOR Appoints Mike Byrnes as Chief Financial Officer,https://www.benzinga.com/pressreleases/21/01/g19056299/effector-appoints-mike-byrnes-as-chief-financial-officer,https://j.mp/3bf2NS7
Benzinga,CytomX Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19056298/cytomx-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference,https://j.mp/2XiS5St
Benzinga,Kaspien and Levin Consulting Announce Partnership to Provide Omnichannel Solutions for Consumer Technology Brands,https://www.benzinga.com/pressreleases/21/01/g19056297/kaspien-and-levin-consulting-announce-partnership-to-provide-omnichannel-solutions-for-consumer-te,https://j.mp/35lpDnk
Benzinga,Silicon Motion Announces Preliminary Fourth Quarter 2020 Revenue and Earnings Conference Call Details,https://www.benzinga.com/pressreleases/21/01/g19056296/silicon-motion-announces-preliminary-fourth-quarter-2020-revenue-and-earnings-conference-call-deta,https://j.mp/39douzx
Benzinga,Notice of Release of Fourth Quarter and Full Year 2020 Results,https://www.benzinga.com/pressreleases/21/01/g19056294/notice-of-release-of-fourth-quarter-and-full-year-2020-results,https://j.mp/3q1LqZ5
Benzinga,Neuronetics Announces Expansion of Sales Organization,https://www.benzinga.com/pressreleases/21/01/g19056293/neuronetics-announces-expansion-of-sales-organization,https://j.mp/2Lp6p9o
Benzinga,"Reliq Health Technologies, Inc. Engages Lytham Partners to Lead U.S. Investor Relations Outreach Program",https://www.benzinga.com/pressreleases/21/01/g19056289/reliq-health-technologies-inc-engages-lytham-partners-to-lead-u-s-investor-relations-outreach-prog,https://j.mp/3s1SjM2
Benzinga,X4 Pharmaceuticals to Present at the H.C. Wainwright Virtual BioConnect Conference,https://www.benzinga.com/pressreleases/21/01/g19056283/x4-pharmaceuticals-to-present-at-the-h-c-wainwright-virtual-bioconnect-conference,https://j.mp/35inbOm
Benzinga,Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19056281/aligos-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference,https://j.mp/3pY1co1
Benzinga,Neoleukin Therapeutics to Present at J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19056276/neoleukin-therapeutics-to-present-at-j-p-morgan-healthcare-conference,https://j.mp/3s231lw
Benzinga,Tempest Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference,https://www.benzinga.com/pressreleases/21/01/g19056270/tempest-therapeutics-to-present-at-the-39th-annual-j-p-morgan-healthcare-conference,https://j.mp/3oo3Eno
Benzinga,LSI Industries Inc. Announces Second Quarter Fiscal 2021 Results Conference Call Date,https://www.benzinga.com/pressreleases/21/01/g19056264/lsi-industries-inc-announces-second-quarter-fiscal-2021-results-conference-call-date,https://j.mp/3s1WSFX
Benzinga,"EV, Hydrogen Vehicles To Benefit From California Governor Newsom's Proposed $1.5 Billion Stimulus",https://www.benzinga.com/government/21/01/19056229/ev-hydrogen-vehicles-to-benefit-from-california-governor-newsoms-proposed-1-5-billion-stimulus,https://j.mp/2XikFDt
